Keyphrases
Prostate Cancer
78%
Prostate Cancer Risk
31%
Finland
31%
Confidence Interval
23%
Prostate Cancer Screening
23%
Androgen Deprivation Therapy
22%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
20%
Prostate
18%
Darolutamide
17%
Laparoscopic Radical Prostatectomy
16%
Statin Use
16%
Hypothyroidism
16%
After Surgery
15%
High-grade Prostate Cancer
14%
Overall Survival
13%
Magnetic Resonance Imaging
13%
Hazard Ratio
13%
Randomized Controlled Trial
13%
Castration-resistant Prostate Cancer
13%
Radical Prostatectomy
13%
Prostate Radiotherapy
13%
Tolerability
13%
Prostate-specific Antigen
13%
Europe
12%
Prognostic Factors
12%
Expanded Prostate Cancer Index Composite
11%
Prostate Cancer Patients
11%
Prostatectomy
11%
European Randomized Study of Screening for Prostate Cancer
11%
Elderly Patients
11%
EPIC-26
11%
Lynch Syndrome
11%
Robot-assisted
11%
Breast Cancer
11%
Three-dimensional (3D)
11%
Randomized Trial
11%
ARAMIS
11%
International Survey
11%
Long Non-coding RNA (LncRNA)
11%
Euthyroid
11%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
11%
Risk of Death
10%
Cancer Mortality
10%
Quality of Life
10%
Statins
9%
Lymph Node Metastasis
9%
Cancer-related
9%
University Hospital
8%
Hypothyroid
8%
Functional Outcome
8%
Reoperation
8%
Oncological Outcomes
7%
Comorbidity
7%
Clinically Significant Prostate Cancer
7%
Population-based Cohort Study
7%
Geoeconomics
7%
Nonmetastatic Prostate Cancer
7%
Economic Factors
7%
Non-muscle Invasive Bladder Cancer (NMIBC)
7%
Bladder Cancer
7%
Urinary Incontinence
7%
Placebo
7%
Treatment-related Adverse Events
6%
Drug Use
6%
Primary Prostate Cancer
6%
Recurrence Rate
6%
Operative Treatment
6%
Disease-specific Mortality
6%
Tampere
6%
Total Prostate-specific Antigen
6%
Enzalutamide
6%
Non-associated
6%
Spouses
6%
Age Groups
6%
Metastasis
6%
Single Center
6%
Levothyroxine
6%
Cancer Treatment
6%
Well-being
6%
Oncogenesis
6%
High Risk
6%
Screening Trials
6%
Sweden
6%
Erectile Dysfunction
6%
Curative Treatment
6%
Cumulative Incidence
6%
Post-diagnostic Support
5%
Tumor
5%
Hernia Repair
5%
Odds Ratio
5%
Gross National Income per Capita
5%
Antihypertensive Drugs
5%
Random Forest Algorithm
5%
Meta-analysis of Randomized Controlled Trials
5%
Genetic Risk Score
5%
Surgical Outcomes
5%
Missingness
5%
Secondary Operation
5%
Population-based
5%
Predictive Biomarker
5%
Medicine and Dentistry
Prostate Cancer
100%
Prostatectomy
30%
Thyroid Gland
22%
Cancer Mortality
18%
Cancer Screening
17%
Magnetic Resonance Imaging
17%
Randomized Controlled Trial
16%
Hypothyroidism
16%
Prostate Specific Antigen
14%
Continence
11%
Malignant Neoplasm
11%
Prognostic Factor
11%
Neoplasm
11%
Elderly Patient
11%
Gene Expression
11%
Hereditary Nonpolyposis Colorectal Cancer
11%
Liotrix
11%
Diseases
9%
Cancer Cell
9%
Arm
9%
Cohort Analysis
9%
Urinary System
9%
Robot-Assisted Prostatectomy
8%
Cancer Therapy
8%
Lymph Node Metastasis
8%
Recurrent Disease
8%
Reoperation
8%
Biopsy Technique
7%
Androgen Receptor
7%
Quality of Life
7%
Overall Survival
7%
Metastatic Carcinoma
7%
Colorectal Carcinoma
7%
Androgen
7%
Comorbidity
7%
Hernioplasty
6%
Surgery
6%
Conservative Treatment
6%
Levothyroxine
6%
Hazard Ratio
6%
Carcinogenesis
6%
Castration Resistant Prostate Cancer
6%
Oncology
6%
Cancer Diagnosis
5%
Circulating Tumor DNA
5%
Social Interaction
5%
microRNA
5%
Rectum Resection
5%
Visual Analog Scale
5%
Brain Ischemia
5%
Masculinity
5%
Thyroid Nodule
5%
Papillary Thyroid Cancer
5%
Kallikrein
5%
Cancer Risk
5%
Breast Cancer
5%
Immunocompetent Cell
5%
Clear Cell Renal Cell Carcinoma
5%
Clinician
5%
Hernia Surgery
5%
Abdominal Wall Hernia
5%
Primary Hyperparathyroidism
5%
Genome Analysis
5%
Maintenance Therapy
5%
Tibial Plateau Fracture
5%
Systematic Review
5%
Non Muscle Invasive Bladder Cancer
5%
Inguinal Hernia
5%
COVID-19
5%
Personalized Medicine
5%
Meta-Analysis
5%
Bladder Cancer
5%
Breast Density
5%
Cross Sectional Study
5%
Cytotoxic T-Cell
5%
Recurrence Risk
5%
Krukenberg Tumor
5%
Cystectomy
5%
Common Bile Duct Stone
5%
Bile Duct Stone
5%
Endoscopic Sphincterotomy
5%
Minimal Residual Disease
5%
Endoscopic Retrograde Cholangiopancreatography
5%
Thyroid Antibody
5%
Long Untranslated RNA
5%
PI3K/AKT/mTOR Pathway
5%
Goiter
5%
Thyroid Hormone
5%
CD3 Antigen
5%
Hypospadias
5%
Thymidine Kinase 1
5%
Acute Coronary Syndrome
5%
Evolution
5%
Urine Incontinence
5%
Enuresis
5%